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PURPOSE. The cornea is continually exposed to highly energetic solar UV-B (280-320 nm).
Our aim was to investigate whether UV-B triggers the activation of NLRP3 inflammasomes
and the production of IL-1β and/or IL-18 in human corneal epithelial (HCE) cells. Addi-
tionally, we studied the capability of cis-urocanic acid (cis-UCA) to prevent inflammasome
activation or alleviate inflammation through other signaling pathways.
METHODS. HCE-2 cell line and primary HCE cells were primed using lipopolysaccharide
or TNF-α. Thereafter, cells were exposed to UV-B before or after the addition of cis-UCA
or caspase-1 inhibitor. Caspase-1 activity was measured from cell lysates by an enzymatic
assay. IL-1β, IL-18, IL-6, IL-8, and NLRP3 levels were detected using the ELISA method
from cell culture media. Additionally, intracellular NLRP3 levels were determined by the
Western blot technique, and cytotoxicity was measured by the LDH assay.
RESULTS. UV-B exposure significantly increased caspase-1 activity in TNF-α-primed HCE
cells. This result was consistent with the concurrently induced IL-1β secretion. Both
caspase-1 activity and release of IL-1β were reduced by cis-UCA. Additionally, UV-B stim-
ulated the caspase-1-independent production of IL-18, an effect also reduced by cis-UCA.
Cis-UCA decreased the release of IL-6, IL-8, and LDH in a time-dependent manner when
administered to HCE-2 cells after UV-B exposure.
CONCLUSIONS. Our findings demonstrate that UV-B activates inflammasomes in HCE cells.
Cis-UCA can prevent the secretion of IL-1β and IL-18 and therapeutically reduces the
levels of IL-6, IL-8, and LDH in UV-B-stressed HCE cells.
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The cornea absorbs a significant amount of ambient UV-B (290-320 nm) and protects the deeper ocular struc-
tures from harmful radiation.1–3 Although UV-B accounts for
only 4% of terrestrial light, it is light with a highly energetic
wavelength, causing many harmful eye conditions, such as
painful photokeratitis and climatic droplet keratopathy.34 At
the cellular level, excessive UV-B evokes corneal phototox-
icity including direct DNA damage, such as the formation
of cyclobutane pyrimidine dimers5 and disturbances in the
antioxidant balance resulting in cellular oxidative stress.6–8
IL-1β and IL-18 are pro-inflammatory cytokines that have
a major role in inflammatory responses.9,10 The secretion
of these cytokines is regulated by intracellular multipro-
tein platforms called inflammasomes. Nucleotide-binding
domain and leucine-rich repeat pyrin-containing protein
3 (NLRP3) is the receptor of the most extensively stud-
ied inflammasome11,12; it can be activated in response to
nonsterile (microbes) or sterile stressors.11 NLRP3 activa-
tion has to be preceded by a priming step,11,12 which trig-
gers the translation of NLRP3 and pro-IL-1β via nuclear
factor-kappa B (NF-κB) signaling.13 IL-18 precursor protein
is constitutively expressed in most of human cells (e.g., in
the corneal epithelial cells, peripheral blood mononuclear
cells, keratinocytes, endothelial cells, and retinal pigment
epithelial cells).14–17
Inflammasome activation occurs when primed cells
sense pathogen-associated molecular patterns or danger-
associated molecular patterns via the NLRP3, which leads
to NLRP3 oligomerization and the assembly of the inflam-
masome multiprotein complex also containing the adap-
tor protein apoptosis-associated speck-like protein contain-
ing a C-terminal caspase recruitment domain (ASC) and the
cysteine protease procaspase-1.18,19 The formation of the
inflammasome complex causes the proteolytic activation of
caspase-1,20,21 which enables the cleavage of pro-IL-1β into
its biologically active and secreted form.21 In conjunction
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with the cleavage of pro-IL-1β, pro-IL-18 requires proteolytic
processing before secretion.22
Urocanic acid (UCA) is a naturally occurring endoge-
nous chromophore produced from histidine in the upper
layer of the epidermis in a deamination reaction catalyzed
by histidase.23 UCA usually occurs as a trans form, but is
converted to the cis isomer in a photoisomerization reac-
tion by UV-B.23,24 Therapeutic effects of cis-UCA have been
studied for nearly three decades. Despite the fact that the
effects of cis-UCA may be cell type-dependent, many in
vivo and in vitro studies have revealed its anti-inflammatory
properties and potential to protect from cell injury.25–28 Our
previous studies have revealed that cis-UCA is well tolerated
by human corneal epithelial (HCE) and conjunctival epithe-
lial (HCEC) cells.29 Additionally, pretreatment with cis-UCA
prevents cell death and the secretion of IL-8 and IL-6 in UV-
B-induced HCE and HCEC cells.29 Moreover, we have shown
that cis-UCA could reduce the activation of activator protein-
1 and mitogen-activated protein kinase pathways in the UV-
B-irradiated HCE-2 cell line.30
Although it is evident that excessive UV-B exposure can
induce an acute inflammatory response in the cornea, its role
in inflammasome signaling is unknown. Because inflamma-
somes are key players in inflammation, we have now inves-
tigated whether the UV-B-induced inflammation is regulated
by the inflammasomes in HCE cells and whether it can be
prevented by cis-UCA. We have also explored the therapeu-
tic potential of cis-UCA by investigating whether it reduces




The human corneal epithelial cell line (HCE-2) was
purchased from the American Type Culture Collection.
HCE-2 cells were cultured in the Keratinocyte Serum Free
growth medium (Life Technologies, Paisley, UK) contain-
ing 50 μg/mL bovine pituitary extract, 5 ng/mL human
recombinant epidermal growth factor 1-53 (EGF 1-53;
both from Life Technologies, Grand Island, NY, USA),
100 U/mL penicillin (Lonza, Walkersville, MD, USA),
100 μg/mL streptomycin (Lonza), and 0.005 mg/mL insulin
(Sigma Aldrich, Saint Louis, MO, USA) at 37°C in a humid-
ified atmosphere with 5% CO2. Cells in passage numbers
ranging from 69 to 86 were used in the study. HCE cell
culture plates for the maintenance (100 mm x 20 mm; Sigma
Aldrich, St. Louis, MO, USA) and 12-well culture plates for the
experiments (Corning Inc., Corning, NY, USA) were coated
with 0.01 mg/mL fibronectin (Sigma-Aldrich), 0.03 mg/mL
collagen (STEMCELL technologies, Vancouver, Canada), and
0.01 mg/mL bovine serum albumin (Roche Diagnostics
GmbH, Mannheim, Germany) in the Keratinocyte Serum
Free Medium. The coating solution was incubated for 30 to
90 minutes at 37°C until replaced by cell suspensions. In
the experiments, cells were seeded on 12-well plates at a
density of 1.5 × 105 cells/mL and incubated for 24 hours in
a humidified 5% CO2 incubator at 37°C.
All tissue collections complied with the Guidelines of
the Helsinki Declaration and were approved by the Local
Ethical Committees (No 2017/418). Human limbal biopsies,
obtained from cadaveric corneo-scleral rings after corneal
transplantation were treated with Dispase II (2.4 U/mL,
Roche Diagnostics) for 10 minutes at 37°C and thereafter
blocked with fetal bovine serum (Sigma-Aldrich), plated on
six-well plates (Corning Inc.) with the epithelial side down
and covered with cell culture medium. Once the limbal
biopsies were attached, they were completely covered and
maintained in DMEM/F12 medium (Thermo Fisher Scien-
tific, Waltham, MA, USA) containing 100 U/mL penicillin,
100 μg/mL streptomycin, 1.25 μg/mL amphotericin B, 5%
FBS, 2 ng/mL human epidermal growth factor, 5 μg/mL
insulin-transferrin-sodium selenite, 15 μM hydrocortisone,
0.5% dimethylsulfoxide, and 30 ng/mL cholera toxin A
(all from Sigma Aldrich) in a humidified 5% CO2 incuba-
tor at 37°C. After the primary HCE (pHCE) cells growing
out from the limbal biopsies had reached confluency, they
were treated with 0.25% Trypsin-EDTA (Sigma Aldrich) and
seeded on 12-well plates (Corning Inc.) at a density of
2.5 × 105 cells/mL and incubated for 48 to 72 hours in a
humidified 5% CO2 incubator at 37°C. Thereafter, the cell
layers were washed and replaced with DMEM/F12 medium
(Thermo) without any supplements.
The priming signal for pHCE and HCE-2 cells was
provided by tumor necrosis factor α (TNF-α, 10 ng/mL;
R&D Systems, Minneapolis, MN, USA) or lipopolysaccharide
(LPS, 1 μg/mL; Sigma Aldrich) by incubating cells for 24 h
in a humidified 5% CO2 incubator at 37°C. Thereafter, cell
cultures were irradiated with UV-B (two TL 20W/12 tubes,
Philips, Eindhoven, The Netherlands) at the energy level of
0.2 J/cm2. The UV-B lamps were calibrated using a spectrora-
diometer (Waldman Variocontrol, Germany) by Istekki Ltd.
(Kuopio, Finland) before the experiments. The irreversible
caspase-1 inhibitor, Ac-YVAD-CMK (200 μM for HCE-2 cells;
Calbiochem, San Diego, CA, USA; or 100 μM for pHCE cells;
Sigma Aldrich) was added to the wells 1 hour before the
UV-B irradiation, where applicable. Additionally, cells were
treated with cis-urocanic acid (cis-UCA, 100 μg/mL, Sigma
Aldrich) 1 hour before or immediately after the UV-B expo-
sure. The concentration of cis-UCA had been optimized in
our previous study.29
Sample Collection
Cell culture medium samples and whole cell lysates were
collected 0.5 to 48 hours after the exposure to UV-B or cis-
UCA, depending on the experiment. Cell culture medium
samples were centrifuged at 380 × g for 10 minutes and
supernatants were transferred into clean tubes. The cells
were rinsed with ice-cold 1x Dulbecco’s phosphate-buffered
saline (Sigma Aldrich) and lysed by addition of the M-
PER solution (Thermo Fisher Scientific) or the cell lysing
buffer provided by the manufacturer of the caspase-1 activ-
ity kit (R&D). Cell lysates prepared using the M-PER solu-
tion were centrifuged at 16 000 × g for 10 minutes at 4°C.
In the measurements of caspase-1 activity, cells from two
to six nonirradiated or four to 12 UV-B-irradiated parallel
wells were collected into one tube and centrifuged accord-
ing to the manufacturers protocol. Before the analyses,
protein concentrations were measured using the Bradford
method.31
ELISA Measurements
IL-1β, IL-6, IL-8 (BD Biosciences, San Diego, CA, USA), IL-
18 (eBioscience, San Diego, CA, USA), and NLRP3 (Cusabio,
Wuhan, China) were measured using the ELISA method from
the cell culture medium according to the manufacturer’s
instructions. Absorbance values were measured at 450 nm
with the reference wavelength of 655 nm by a spectropho-
tometer (Biorad, Model 550, Hercules, CA, USA).
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Caspase-1 Activity
Caspase-1 activity was measured using the caspase-1 colori-
metric assay according to the manufacturer’s protocol.
Absorbance values were determined at a wavelength of
405 nm by a spectrophotometer (ELx808, Biotek Instru-
ments Inc.,Winooski, VT, USA). The kit supplements without
cell lysates were used as blank samples. Thereafter, blank-
subtracted results were normalized to protein concentrations
and expressed as a ratio to the untreated cells.
Cytotoxicity Measurements
The quantity of LDHwas measured from cell culture medium
samples using the CytoTox96 Non-Radioactive Cytotoxic-
ity assay (Promega Corporation, Madison, WI, USA) accord-
ing to the manufacturer’s instructions. Colorimetric reactions
were monitored at a wavelength of 490 nm in a spectropho-
tometer (Biorad).
Western Blot
Equal amounts of protein (20-40 μg in HCE-2 cell lysates
or 5-10 μg in primary HCE cell lysates) were run in 10%
SDS-PAGE gels and wet-blotted overnight onto nitrocellu-
lose membranes (GE Healthcare, Little Chalfont, Bucking-
hamshire, UK). Ponceau S (Sigma-Aldrich) staining was used
to ensure the accurate protein transfer from the gels to the
membranes. The membranes were blocked with 5% milk
in 0.1% Tween-20/Tris-buffered saline for 1 hour at room
temperature (RT). The Tween/Tris-buffered saline solution
was also used as a washing buffer and a diluent for the anti-
bodies. Thereafter, the membranes were incubated with an
anti-CIAS1/NALP3 (1:1000; cat. 109314, Abcam, Cambridge,
UK) monoclonal rabbit antibody overnight at +4°C. The
membranes were washed 3 × 5 minutes with washing buffer
followed by a 2-hour incubation at RT with a horseradish
peroxidase-conjugated anti-rabbit IgG antibody (1:5 000,
cat. A16104, Novex) in blocking buffer. The washing steps
were repeated and the NLRP3 protein-antibody complexes
were detected using the enhanced chemiluminescent assay
after the addition of the substrate (Millipore, Billerica, MA,
USA). The band intensities given by NLRP3 were normal-
ized to α-tubulin values using a monoclonal mouse α-tubulin
(1:8000; cat. T5168, Sigma Aldrich). Following the incubation
for 15 minutes at RT, membranes were washed three times
for 5 minutes. Polyclonal horseradish peroxidase-conjugated
sheep anti-mouse IgG (1:10 000; cat. NA931, GE Health-
care) was used as a secondary antibody and incubated for
15 minutes at RT before performing the washing and detec-
tion steps as described previously. All the results were quan-
tified using the ImageJ program (http:// rsb.info.nih.gov/ ij/
index.html).
Confocal Imaging of DsRed-ASC
HCE-2 cells were cultured on eight-well chamber slides
(Ibidi GmbH,Martinsried, Germany) at a density of 4.5 × 104
cells/well. Sub-confluent (70%-80%) cell layers were trans-
fected with DsRed-ASC plasmid construct (20 ng) along with
ExGen500 transfection reagent (Thermo Fischer Scientific,
Waltham, MA, USA). The cells were incubated for 24 hours in
a humidified 5% CO2 incubator at 37°C followed by a prim-
ing with TNF-α (10 ng/mL) for the next 24 hours. Thereafter,
ASC specks were observed under the confocal microscope
(Zeiss Axio Observer inverted microscope with Zeiss LSM
700 confocal module) at 5 and 24 hours upon UV-B expo-
sure (0.2 J/cm2).
Statistical Analyses
All results were analyzed using the GraphPad Prism program
(GraphPad Software Version 7.04, San Diego, CA, USA). Pair-
wise comparisons were performed using the Mann-Whitney
U-test, and P values ≤ 0.05 were considered statistically
significant.
RESULTS
UV-B Exposure Induces Caspase-1 Dependent
Secretion of IL-1β in HCE Cells
To examine the ability of UV-B to activate inflammasomes in
HCE-2 cells, cell cultures were primed with LPS or TNF-α and
subsequently exposed to UV-B light. LPS and TNF-α-primed
and UV-B-treated HCE-2 cells secreted higher amounts of
IL-1β (1.6-fold in the LPS-treated cells and 3.0-fold in the
TNF-α-primed cells) compared with LPS or TNF-α-treated
controls (mean for LPS: 0.3 pg/ml vs. LPS + UV-B: 0.4
pg/mL, P < 0.001, Fig. 1 A; TNF-α: 0.5 pg/mL vs. TNF-α
+ UV-B: 1.7 pg/mL, P < 0.0001, Fig. 1 B). Additionally, UV-
B without priming tripled the IL-1β levels when compared
to untreated control cells (mean for untreated control:
0.1 pg/mL vs. UV-B: 0.3 pg/mL; Figs. 1 A–B) although the
levels were 1.4 (P < 0.01) and 4.1 (P < 0.0001) times lower
when compared to LPS or TNF-α-primed and UV-B-treated
cells, respectively.
The results with the pHCEs were in line with those
obtained with HCE-2 cells, showing that the secretion of
IL-1β was increased after the UV-B exposure (untreated
control: 22.2 pg/mL vs. UV-B: 111.0 pg/mL, P < 0.0001;
TNF-α: 52.0 pg/mL vs. TNF-α + UV-B: 326.2 pg/mL,
P < 0.0001; Fig. 1 C). Once again, TNF-α + UV-B-
treated cells significantly augmented the production of IL-
1β when compared with UV-B-treated cells without prim-
ing (P < 0.0001; Fig. 1 C). Overall, TNF-α + UV-B-
treatment induced a much greater, (i.e., 190-fold eleva-
tions) response of IL-1β in pHCE cells (TNF-α + UV-B:
326.2 pg/mL) in comparison to the HCE-2 cell line (TNF-
α + UV-B: 1.7 pg/mL). LDH data showed that the increased
cytokine levels were not attributable to the passive leakage
of proteins (UV-B vs. TNF-α + UV-B, P > 0.05; Fig. 1 D).
Moreover, the addition of a selective caspase-1 inhibitor
significantly mitigated the secretion of IL-1β in UV-B-
irradiated HCE-2 (P < 0.001, Fig. 1 E) and cultured primary
HCE cells (P < 0.05; Fig. 1 F), evidence of a role in inflamma-
some signaling in the production of IL-1β. It was confirmed
with the LDH assay that caspase-1 inhibitor was not toxic to
the HCE cells (TNF-α + UV-B vs. TNF-α + caspase-1 inhibitor
+ UV-B, P > 0.05; Fig. 1 G).
UV-B Induces the Caspase-1-Independent
Secretion of IL-18 in Human Corneal Epithelial
Cells
Next, we evaluated whether the secretion of IL-18 was upreg-
ulated after the UV-B exposure in HCE cells. Instead of
LPS priming, only TNF-α was used to prime cells since
it resulted in 4.25 times higher concentration of IL-1β in
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FIGURE 1. Caspase-1-dependent secretion of IL-1β in UV-B-stimulated HCE-2 and primary HCE cells. HCE-2 cells were primed for 24
hours either with LPS (1 μg/mL; A) or TNF-α (10 ng/mL; B) followed by irradiation with UV-B (0.2 J/cm2). The secretion of IL-1β was
measured by the ELISA method from HCE cell culture media for 24 hours after the UV-B irradiation. The levels of IL-1β were combined from
three independent experiments with five to six parallel samples per group. Additionally, levels of IL-1β and LDH were measured from the
primary HCE cell culture media from eight donors with one to three parallel samples per donor (C-D). Alternatively, HCE-2 (E) or primary
HCE (F-G) cells were pretreated with the caspase-1 inhibitor (200 μM [E] or 100 μM [F-G] for 1 hour before the UV-B exposure). IL-1β data
from HCE-2 cells (E) have been combined from three independent experiments each with 10 to 12 parallel samples. IL-1β and LDH data
from cultured primary HCE cells (F-G) have been combined from four donors with one to two parallel samples per donor. All data are
presented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ns = not significant, Mann-Whitney U-test; pHCE = primary HCE cells; casp.1
inh. = caspase-1 inhibitor.
UV-B-irradiated HCE-2 cells (LPS + UV-B: 0.4 pg/mL and
TNF-α + UV-B: 1.7 pg/mL; Figs. 1 A-B). In line with the
IL-1β findings, the secretion of IL-18 was increased after
the UV-B irradiation (untreated control: 23.7 pg/mL, UV-B:
98.1 pg/mL; P < 0.01). Similarly, UV-B-induced the secretion
of IL-18 in TNF-α-treated pHCE cells (TNF-α: 40.0 pg/mL,
TNF-α + UV-B: 105.3 pg/mL; P < 0.001; Fig. 2 A). There was
no difference in the levels of IL-18 when UV-B and TNF-
α + UV-B-treated cells were compared with each other (P
> 0.05; Fig. 2 A). Surprisingly, treatment with the caspase-
1 inhibitor did not reduce the secretion of IL-18 (P >
0.05; Fig. 2 B), suggesting that UV-B does not cause the
maturation IL-18 via a caspase-1-dependent mechanism in
HCE cells.
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FIGURE 2. Caspase-1-independent release of IL-18 in UV-B-irradiated primary HCE cells. Primary HCE cells were treated with TNF-α
(10 ng/mL) for 24 hours followed by irradiation under UV-B light (0.2 J/cm2). The secretion of IL-18 was measured for 24 hours after the
UV-B exposure from the cell culture medium samples (A). Alternatively, cells were pretreated with the caspase-1 inhibitor (100 μM) at 1
hour before UV-B irradiation (B). ELISA results of extracellular IL-18 have been combined from (A) three or (B) two donors with two parallel
samples per donor. Data are represented as mean ± SEM. **P < 0.01, ***P < 0.001, ns = not significant, Mann-Whitney U-test; casp.1 inh. =
caspase-1 inhibitor.
NLRP3 is Secreted After the UV-B Irradiation from
TNF-α-Primed Human Corneal Epithelial Cells
TNF-α significantly increased the levels of intracellular
NLRP3 in HCE-2 cells (P < 0.001; Fig. 3 A), suggesting an
efficient priming signal for the cells. NLRP3 was released
out of the cells following the inflammasome activation, as
shown by the 2.3-fold reduction in the levels of intracellular
NLRP3 (P < 0.01) and the 3.5-fold increase in the cell culture
medium (P < 0.001) in TNF-α + UV-B-treated HCE-2 cells
in comparison to TNF-α-treated control cells (Figs. 3 A-B).
Additionally, TNF-α induced the secretion of NLRP3 in
comparison to untreated controls (P < 0.001; Fig. 3 B),
though the levels were 3.5 times lower when compared
with the TNF-α + UV-B group. Exposure to UV-B without
the priming signal was not essential for the induction of
NLRP3 in HCE-2 cells since the intracellular or extracellular
levels of NLRP3 showed no change upon exposure (P> 0.05,
Figs. 3 A-B). Unlike HCE-2 cells, intracellular NLRP3 levels
were increased in TNF-α-primed pHCE cells after the UV-B
exposure (P < 0.05; Fig. 3 C). Moreover, NLRP3 was released
out of the primed pHCE cells after the UV-B exposure, while
instead of UV-B (P > 0.05; Fig. 3 D), TNF-α highly induced
the secretion of NLRP3 (P < 0.001; Fig. 3 D) when compared
with untreated control.
UV-B Affects Formation of ASC Specks in Human
Corneal Epithelial Cells
Thereafter, we studied further the activation of NLRP3 by
measuring ASC specks upon UV-B irradiation in HCE-2 cells
under the confocal microscope. UV-B clearly induced the
formation of ASC specks already 5 hours upon UV-B expo-
sure when compared with untreated control (Figs. 4 A-C).
Additionally, ASC specks were observed at the 24 h time-
point upon UV-B irradiation in TNF-α + UV-B-irradiated cells
but not in untreated control (Figs. 4 D-E). These findings
support our other data that UV-B exposure in primed HCE
cells activates the assembly of inflammasomes.
cis-UCA Prevents the UV-B-Induced Secretion of
IL-1β, IL-18, and LDH from Human Corneal
Epithelial Cells
Next, the ability of cis-UCA to modulate the UV-B-induced
inflammasome activation was studied. Cis-UCA reduced
the UV-B-induced caspase-1 activity in HCE-2 cells (P <
0.05; Fig. 5 A). Subsequent experiments with the HCE-2 cell
line revealed that cis-UCA reduced the production of IL-
1β (P < 0.001; Fig. 5 B). In an attempt to confirm these
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FIGURE 3. Fate of NLRP3 in UV-B-stressed HCE cells. HCE-2 cells were primed for 24 hours with TNF-α (10 ng/mL) following irradiation
with UV-B (0.2 J/cm2), and then incubated for 24 hours before sample collection and analysis. Intracellular levels of NLRP3 (iNLRP3; A)
were measured by the Western blot technique from cell lysates and the levels of NLRP3 were normalized to those of α-tubulin. Data in panel
A is combined from two (UV-B) to four (untreated control, TNF-α, TNF-α + UV-B the correct group is TNF-α + UVB. This means that extra
red comma should be removed.) independent experiments with three to four parallel samples in each group. Extracellular levels of NLRP3
(eNLRP3; B) were measured by the ELISA method from HCE-2 cell culture supernatants and data were combined from three independent
experiments with three parallel samples in each group. Experiments were repeated using primary HCE cells, and intracellular levels of
NLRP3 were measured by Western blot from cells of four donors (C), and extracellular levels of NLRP3 by ELISA from four donors with two
parallel samples (D). (E, F) Representative Western blots from NLRP3 and α-tubulin measurements of (A) HCE-2 cells lysates or (C) primary
HCE cell lysates. All data are presented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ns = not significant, Mann-Whitney U-test; +
the NLRP3 positive control + equals to the NLRP3 positive control.
findings, we found that cis-UCA decreased by 6.9 times the
secretion of IL-1β when compared with UV-B-treated pHCE
cells without cis-UCA pretreatment (mean for TNF-α + UV-
B: 203.1 pg/mL vs. TNF-α + cis-UCA + UV-B: 29.4 pg/mL,
P < 0.001; Fig. 5 C). Actually, cis-UCA restored the release
of IL-1β back to the baseline level of non-irradiated pHCE
cells (TNF-α: 26.5 pg/mL vs. TNF-α + cis-UCA + UV-B: 29.4
pg/mL, P > 0.05; Fig. 5 C).
In line with the IL-1β results, cis-UCA reduced the IL-18
secretion by 3.9 times when compared with TNF-α +
UV-B-treated cells without cis-UCA (TNF-α + UV-B: 91.5
pg/mL and TNF-α + cis-UCA + UV-B: 23.6 pg/mL, P <
0.05; Fig. 5 D). Moreover, cis-UCA restored the production
of IL-18 back to the nonirradiated control level (P > 0.05;
Fig. 5 D). Collectively, these results suggest that cis-UCA
was able to inhibit the inflammasome-dependent secretion
of IL-1β as well as the inflammasome-independent secretion
of IL-18.
In cell viability assays, cis-UCA significantly protected
pHCE cells from UV-B-induced cell death (TNF-α + UV-
B vs. TNF-α + cis-UCA + UV-B, P < 0.001; Fig. 5 E). In
line with the cytokine results, LDH release remained at the
baseline level if cis-UCA had been provided to the UV-B-
irradiated pHCE cells (TNF-α vs. TNF-α + cis-UCA + UV-B,
P > 0.05; Fig. 5 E).
cis-UCA has a Therapeutic Effect on the Release
of IL-8, IL-6, and LDH in HCE-2 Cells when
Applied After the UV-B Exposure
Finally, we investigated the therapeutic potential of cis-UCA
by applying it to HCE-2 cell cultures after the UV-B irradi-
ation. Cis-UCA significantly reduced the secretion of both
IL-8 (P < 0.001; Fig. 6 A) and IL-6 (P < 0.01-0.001; Fig. 6 B)
at all five time points (0.5, 4, 6, 24, and 48 hours) when
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FIGURE 4. The formation of ASC specks upon UV-B irradiation in HCE cells. HCE-2 cells were transfected with DsRed-ASC plasmid
constructs for 24 hours and primed for the next 24 hours with TNF-α (10 ng/mL). HCE-2 cells were observed under the confocal microscope 5
hours after the UV-B exposure (0.2 J/cm2; A = control group and B-C = TNF-α + UV-B treated group). Alternatively, microscopic examinations
were performed 24 hours after the UV-B irradiation (D = control group and E = TNF-α + UV-B treated group). Experiments were repeated
three times and images were photographed using the 63-fold objective (A-C: scale bar, 5 μm; D-E: scale bar, 10 μm). White arrows indicate
ASC specks. N = nucleus, C = cytoplasm.
compared with cells exposed only to UV-B. Cis-UCA reduced
the secretion of IL-8 and IL-6 even under the basal control
level at the 0.5 hours time point (IL-8 from untreated control:
1 vs. UV-B + cis-UCA: 0.2, Fig. 6 A; IL-6 from untreated
control: 1 vs. UV-B + cis-UCA: 0.1, Fig. 6 B). According to
the cell viability assay assessed with LDH release, already
at 6 hours after the UV-B exposure, if cis-UCA was not
present, then UV-B slightly increased the rupturing of the
cell membrane (Fig. 6 C). At 24 and 48 hours after UV-B-
irradiation, the level of LDH was 2.6 and 2.4 times higher
when compared with untreated control cells, respectively
(Fig. 6 C). Consequently, cis-UCA resulted in 1.2 (P < 0.05)
and 1.2 (P < 0.001) times lower LDH release when this was
assessed at 24 and 48 hours after cis-UCA treatment, respec-
tively (Fig. 6 C). Interestingly, even at the 0.5 hour time point,
treatment with cis-UCA increased cell viability as compared
with the untreated control (untreated control: 1 vs. UV-B +
cis-UCA: 0.53, P < 0.001; Fig. 6 C).
DISCUSSION
NLRP3 inflammasomes are intracellular protein complexes,
and their activation plays a key role in immune responses.32
In the present study, UV-B irradiation was found to induce
the NLRP3-mediated activation of caspase-1 and concur-
rently elevated the levels of IL-1β in the HCE cell line and
pHCE cells. This finding is in line with the reports of Feld-
meyer et al.33 and Hasegawa et al.34 that UV-B is able to acti-
vate NLRP3 inflammasomes leading to the release of IL-1β
from the keratinocytes of human skin.33,34
Although both TNF-α and LPS are able to provide a prim-
ing signal in UV-B-stressed HCE-2 cells and can increase the
secretion of IL-1β, TNF-α appeared to be a more potent prim-
ing agent in this study. In fact, recently it has been claimed
that TNF-α is a more selective priming factor for NLRP3 in
comparison to LPS.35 Additionally, in our corneal cells, UV-B
alone resulted in increased IL-1β release in nonprimed HCE
cells; even greater cytokine production was dependent on
priming, which is a characteristic of the NLRP3 inflamma-
some.36 It has been shown previously that UV-B exposure
can trigger the expression of IL-1β mRNA in non-primed
HCE cells,6 which suggests that UV-B not only activates but
also induces the expression of IL-1β. It has been reported
that UV-B possesses an ability to activate TNF-R1 recep-
tors on the cell membrane,37 explaining the UV-B-dependent
expression of pro-IL-1β.
In the present study, intracellular NLRP3 levels were
increased in primed pHCE cells but decreased in primed
HCE-2 cells after UV-B exposure. Our NLRP3 antibody binds
to the N´-terminus of NLRP3 protein (1-150 aa), which is the
location of PYD-domain of NLRP3. PYD is a domain that
interacts with ASC in the assembly of the inflammasome
complex.38 Therefore, the changes observed here seem to
be dependent on the amount of PYD domain available, irre-
spective of whether there is a simultaneous activation of the
inflammasome. Although UV-B alone increased the produc-
tion of IL-1β, it did not affect the levels of intracellular NLRP3
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FIGURE 5. Preventive effect of cis-UCA on the secretion of IL-1β and IL-18 in UV-B-stressed HCE cells. TNF-α–primed (10 ng/mL)
HCE cells were pretreated with cis-UCA (100 μg/mL) for 1 hour followed by irradiation with UV-B (0.2 J/cm2). (A) Caspase-1 activity was
measured from HCE-2 cell lysates by an enzymatic assay and (B) IL-1β levels from HCE-2 cell culture medium samples by the ELISA method
at 24 hours after the UV-B exposure. Data for caspase-1 activity were combined from two independent experiments with three parallel
samples per group, and data of IL-1β were combined from three independent experiments with 10 to 12 parallel samples per group in each
experiment. The results were confirmed in primary HCE cells where the amounts of (C) IL-1β, (D) IL-18, and (E) LDH were measured. Levels
of IL-1β (C) and LDH (E) were investigated from four donors with three (TNF-α) or two (UV-B, TNF-α + UV-B, TNF-α + cis-UCA + UV-B)
parallel samples from each donor. (D) IL-18 was measured from two donors with two parallel samples from each donor. All data are shown
as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ns = not significant, Mann-Whitney U-test.
FIGURE 6. Therapeutic effect of cis-UCA on the secretion of IL-8, IL-6, and LDH in UV-B-exposed HCE-2 cells.HCE-2 cells were exposed
to UV-B (0.2 J/cm2) and subsequently treated with cis-UCA (100 μg/mL). Cell culture mediums were collected either 0.5, 4, 6, 24, or 48 hours
after the cis-UCA application, and the secretion levels of (A) IL-8 and (B) IL-6 were measured by an ELISA method. (C) Cell membrane
integrity was assessed with the LDH assay. (A-C) Results have been converted into the mean of untreated control cells, which is presented
in the figure as 1 (dotted line). UV-B ( • ) and UV-B + cis-UCA ( ◦ ) groups were compared at every time point and the differences were
analyzed with the Mann-Whitney U-test. Results are represented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, ns = not significant.
in either cultured pHCE or HCE-2 cells. Previously Benko et
al.39 found that UV-B stimulated the expression of NLRP3
mRNA but the protein concentration did not increase after
UV-B irradiation in nonprimed HCE cells, which is in line
with the present study. Overall, the levels of intracellular
NLRP3 do not reveal whether or not inflammasomes have
been activated. The activity of caspase-1 is a more accurate;
it became activated in both TNF-α-primed HCE-2 and pHCE
cells upon UV-B exposure.
In TNF-α-primed HCE cells, the fate of NLRP3 after
inflammasome activation depended on the origin of the
cells. Thus, UV-B induced higher secretion of NLRP3 in
TNF-α primed HCE-2 cells in comparison to pHCE cells.
This may be due to different kinetics in the release of
inflammasome particles when comparing a cell line to
primary cells. We have recently examined ARPE-19 cells
and observed that NLRP3 can be either secreted out of the
cells or degraded by autophagy following inflammasome
Downloaded from iovs.arvojournals.org on 06/16/2020
UCA Prevents UV-B-Induced Inflammasome Activation IOVS | April 2020 | Vol. 61 | No. 4 | Article 7 | 9
activation.40 Additionally, extracellular components of the
inflammasome have been detected previously from blood
monocyte-derived macrophages, from the serum of patients
suffering from cryopyrin-associated periodic syndrome,41
and in the bronchoalveolar lavage taken from patients
with chronic obstructive pulmonary disease and pneumo-
nia.42 Moreover, increased NLRP3 protein levels have been
detected from the ocular surface epithelium of patients with
non-Sjögren syndrome dry eye,43 which could be evidence of
the local accumulation of cellular NLRP3 protein in corneal
diseases. In the present study, TNF-α alone was also capable
of releasing NLRP3 and not simply in pHCE cells followed by
UV-B irradiation. It has been reported that TNF-α itself has
the capability to induce reactive oxygen species-dependent
inflammasome activation and IL-1β production in neurob-
lastoma cells,44 which could support the idea that NLRP3
is secreted out of the cell upon TNF-α-mediated inflam-
masome activation. According to our data, it appears that
TNF-α triggers the secretion of NLRP3 in the absence of
an activating signal. This may be the case with the pHCE
cells, where NLRP3 was secreted out of the cell in a TNF-
α-independent manner on the levels of intracellular NLRP3
or IL-1β. We have recently reported similar findings in
Hsp90-inhibited ARPE-19 cells where inactive NLRP3 was
secreted out of the cells in addition to being degraded by
autophagy.40
Apart from IL-1β, the release of another inflammasome-
regulated cytokine, IL-18, was studied here from UV-B-
stimulated HCE cells. Although priming was needed to
enhance the secretion of IL-1β, pro-forms of IL-18 appeared
to be constitutively present in HCE cells. In 2001, Burbach et
al. were the first to demonstrate the constitutive expression
of IL-18 in primary corneal epithelial cells.14 Additionally, the
same publication revealed that in the corneal epithelial cells,
the amounts of secreted and cell-associated IL-18 could be
increased by treatment with phorbol 12-myristate 13-acetate,
LPS, or double-stranded RNA (poly dI:dC).14 Because the IL-
18 ELISA kit used in our study measures only the mature
form of this cytokine, we concluded that UV-B had induced
the secretion of bioactive IL-18. Additionally, we found that
IL-18 release was not dependent on the caspase-1 activa-
tion, which may indicate that IL-18 does not require NLRP3
inflammasome for its cleavage. Previously, it has been shown
that several factors (e.g., epithelial cell-derived metallopro-
teinase Meprin β,45 mast cell derived chymase,46 caspase-8,47
and NK cell-derived granzyme B48) are capable of inducing
inflammasome-independent secretion of IL-18. Interestingly,
UV-B irradiation has been shown to express granzyme B in
human keratinocytes.49
Cis-UCA appears to be a promising anti-inflammatory
compound because we observed here that cis-UCA reduced
the secretion of IL-1β and IL-18 as well as the activity
of caspase-1 in HCE cells. Additionally, we demonstrated
that cis-UCA possessed therapeutic properties because it
decreased the secretion of IL-6 and IL-8 and alleviated
cell death even when administered after the UV-B expo-
sure. We have recently confirmed in a clinical phase I
study that 0.5% and 2.5% cis-UCA eye drops are well-
tolerated after topical administration to the cornea50 and
there was no evidence of systemic accumulation or systemic
or local side effects upon repeated topical administration
of 5% cis-UCA in randomized phase I/IIa dermatologi-
cal trials.51 Although the mechanism behind the capacity
of cis-UCA to regulate immune responses has been stud-
ied widely past 3 decades, it still remains fully unsolved.
In our previous studies, cis-UCA was able to prevent
IL-8 and IL-6 secretion via the c-Jun/activator protein-1
and JNK/mitogen activated protein kinase pathways.29,30
Instead, Walterscheid et al. have previously reported that
the immune suppressive effect of cis-UCA is mediated
through the activation of 5-hydroxytryptamine receptor 2 A
(5-HTR2A) in mice,52 whereas Cloëz-Tayarani and colleagues
showed that the stimulation of 5-HT rather increased than
decreased the production of IL-1β through 5-HTR2A in LPS-
stimulated human PBMCs.53 In another study, 5-HT stimu-
lation increased the production of IL-1β but not that of IL-
18 in LPS-treated human blood monocytes.54 In the study
of Dürk et al., IL-1β secretion was mediated via 5-HTR3,
5-HTR4, and 5-HTR7 instead of 5-HTR2A.54 In our present
study, productions of IL-1β and IL-18 were regulated via
distinct signaling pathways but cis-UCA reduced the secre-
tion of both of these cytokines, which along with previous
findings propose that IL-1β and IL-18 secretion may not
be regulated by 5-HTR2A. Alternatively, cis-UCA has been
reported to exert a protodynamic effect in cell cultures,
which means that it is capable of transporting protons
from a mildly acidic extracellular matrix into the cell.55
Because extracellular acidosis is a danger signal for the acti-
vation of NLRP3 inflammasome through the K+ efflux,56
it could be hypothesized that cis-UCA acts to regulate the
balance of K+ levels between the cytosol and the extracel-
lular space. UV-B is known to trigger K+ efflux in human
corneal limbal epithelial cells,57 and the inhibition of K+
efflux is one way to inhibit inflammasome activation and
reduce the levels of IL-1β.58,59 Moreover, reactive oxygen
species production has been shown to increase the amounts
of the pro-form of IL-1β and to promote its maturation via
the NLRP3 inflammasome in hyperosmolarity-induced HCE-
2 cells.60 That could serve as another way to investigate the
silencing mechanism of cis-UCA in UV-B-activated inflam-
masome signaling. The present study provides new insights
to study molecular mechanism of cis-UCA, which has now
been associated for the first time with the UV-B-induced
activation of inflammasomes in human corneal epithelial
cells.
Because cis-UCA can inhibit the secretion of IL-1β and
IL-18 along with its cytoprotective and therapeutic effects, it
may well find extensive applications in several pathological
conditions (e.g., pterygium, photokeratitis, CDK, and ocular
surface squamous neoplasia where UV-B causes cell damage
and inflammation).3,4
Acknowledgments
The authors thank Anne Seppänen, Matti Onnela, and Tiia
Suomalainen for technical assistance; Ewen MacDonald for
language revision; and Antero Salminen for valuable discussions
and critical review of the manuscript.
Supported by the Päivikki and Sakari Sohlberg Founda-
tion, Finnish Cultural Foundation (North-Savo Regional Fund),
Emil Aaltonen Foundation, the Academy of Finland (Health
Research Council projects AK328443, AK297267, AK307341, and
KK5503743), Mary and Georg C. Ehrnrooth Foundation, Sokeain
ystävät ry, and Silmä- ja Kudospankkisäätiö.
Disclosure: E. Korhonen, None; J. Bisevac, None; J.M.T. Hytti-
nen, None; N. Piippo, None; M. Hytti, None; K. Kaarniranta,
None; G. Petrovski, None; A. Kauppinen, None
Downloaded from iovs.arvojournals.org on 06/16/2020
UCA Prevents UV-B-Induced Inflammasome Activation IOVS | April 2020 | Vol. 61 | No. 4 | Article 7 | 10
References
1. Kolozsvári L, Nógrádi A, Hopp B, Bor Z. UV absorbance
of the human cornea in the 240- to 400-nm range. Invest
Ophthalmol Vis Sci. 2002;43:2165–2168.
2. Ringvold A. Corneal epithelium and UV-protection of the
eye. Acta Ophthalmol Scand. 1998;76:149–153.
3. Delic NC, Lyons JG, Di Girolamo N, Halliday GM. Damag-
ing effects of ultraviolet radiation on the cornea. Photochem
Photobiol. 2017;93:920–929.
4. Serra HM, Holopainen JM, Beuerman R, Kaarniranta K,
Suárez MF, Urrets-Zavalía JA. Climatic droplet keratopa-
thy: an old disease in new clothes. Acta Ophthalmol.
2015;93:496–504.
5. Mallet JD, Rochette PJ. Wavelength-dependent ultraviolet
induction of cyclobutane pyrimidine dimers in the human
cornea. Photochem Photobiol Sci. 2013;12:1310–1318.
6. Black AT, Gordon MK, Heck DE, Gallo MA, Laskin DL,
Laskin JD. UVB light regulates expression of antioxidants
and inflammatory mediators in human corneal epithelial
cells. Biochem Pharmacol. 2011;81:873–880.
7. Cejková J, Stípek S, Crkovská J, et al. UV Rays, the prooxi-
dant/antioxidant imbalance in the cornea and oxidative eye
damage. Physiol Res. 2004;53:1–10.
8. Zheng R, Po I, Mishin V, et al. The generation of 4-
hydroxynonenal, an electrophilic lipid peroxidation end
product, in rabbit cornea organ cultures treated with
UVB light and nitrogen mustard. Toxicol Appl Pharmacol.
2013;272:345–355.
9. Garlanda C, Dinarello CA, Mantovani A. The interleukin-1
family: back to the future. Immunity. 2013;39:1003–1018.
10. Keyel PA. How is inflammation initiated? Individual influ-
ences of IL-1, IL-18 and HMGB1. Cytokine. 2014;69:136–145.
11. Malik A, Kanneganti T. Inflammasome activation and assem-
bly at a glance. J Cell Sci. 2017;130:3955–3963.
12. Gross O, Thomas CJ, Guarda G, Tschopp J. The inflamma-
some: an integrated view. Immunol Rev. 2011;243:136–151.
13. Bauernfeind FG, Horvath G, Stutz A, et al. Cutting edge: NF-
kappaB activating pattern recognition and cytokine recep-
tors license NLRP3 inflammasome activation by regulating
NLRP3 expression. J Immunol. 2009;183:787–791.
14. Burbach GJ, Naik SM,Harten JB, et al. Interleukin-18 expres-
sion and modulation in human corneal epithelial cells. Curr
Eye Res. 2001;23:64–68.
15. Novick D, Kim S, Kaplanski G, Dinarello CA. Interleukin-18,
more than a Th1 cytokine. Semin Immunol. 2013;25:439–
448.
16. Puren AJ, Fantuzzi G, Dinarello CA. Gene expression,
synthesis, and secretion of interleukin 18 and interleukin
1beta are differentially regulated in human blood mononu-
clear cells and mouse spleen cells. Proc Natl Acad Sci USA.
1999;96:2256–2261.
17. Shi G, Chen S, Wandu WS, et al. Inflammasomes induced
by 7-ketocholesterol and other stimuli in RPE and in bone
marrow–derived cells differ markedly in their production of
IL-1β and IL-18. Invest Ophthalmol Vis Sci. 2015;56:1658–
1664.
18. He Y, Hara H, Núñez G. Mechanism and regulation
of NLRP3 inflammasome activation. Trends Biochem Sci.
2016;41:1012–1021.
19. Jo E, Kim JK, Shin D, Sasakawa C. Molecular mecha-
nisms regulating NLRP3 inflammasome activation. Cell Mol
Immunol. 2016;13:148–159.
20. Martinon F, Burns K, Tschopp J. The inflammasome:
a molecular platform triggering activation of inflamma-
tory caspases and processing of proIL-beta. Mol Cell.
2002;10:417–426.
21. Sutterwala FS, Ogura Y, Szczepanik M, et al. Critical role for
NALP3/CIAS1/cryopyrin in innate and adaptive immunity
through its regulation of caspase-1. Immunity. 2006;24:317–
327.
22. Afonina IS, Müller C, Martin SJ, Beyaert R. Proteolytic
processing of interleukin-1 family cytokines: variations on
a common theme. Immunity. 2015;42:991–1004.
23. Gibbs NK, Tye J, Norval M. Recent advances in urocanic
acid photochemistry, photobiology and photoimmunology.
Photochem Photobiol Sci. 2008;7:655–667.
24. McLoone P, Simics E, Barton A, Norval M, Gibbs NK. An
action spectrum for the production of cis-urocanic acid in
human skin in vivo. J Invest Dermatol. 2005;124:1071–1074.
25. Albert E, Walker J, Thiesen A, Churchill T, Madsen K. cis-
Urocanic acid attenuates acute dextran sodium sulphate-
induced intestinal inflammation. PLoS ONE. 2010;5:e13676.
26. Konkol Y, Bernoulli J, Streng T, Jääskeläinen K, Laihia
J, Leino L. Intravesical treatment with cis-urocanic acid
improves bladder function in rat model of acute bladder
inflammation. Neurourol Urodyn. 2016;35:786–791.
27. Laihia JK, Taimen P, Kujari H, Leino L. Topical cis-urocanic
acid attenuates oedema and erythema in acute and suba-
cute skin inflammation in the mouse. Br J Dermatol.
2012;167:506–513.
28. Peltonen JM, Pylkkänen L, Jansén CT, et al. Three
randomised phase I/IIa trials of 5% cis-urocanic acid emul-
sion cream in healthy adult subjects and in patients with
atopic dermatitis. Acta Derm Venereol. 2014;94:415–420.
29. Viiri J, Jauhonen HM, Kauppinen A, et al. Cis-urocanic acid
suppresses UV-B-induced interleukin-6 and -8 secretion and
cytotoxicity in human corneal and conjunctival epithelial
cells in vitro. Mol Vis. 2009;15:1799–1805.
30. Jauhonen H, Kauppinen A, Paimela T, et al. Cis-
urocanic acid inhibits SAPK/JNK signaling pathway in UV-
B exposed human corneal epithelial cells in vitro. Mol Vis.
2011;17:2311–2317.
31. Bradford MM. A rapid and sensitive method for the quantita-
tion of microgram quantities of protein utilizing the princi-
ple of protein-dye binding. Anal Biochem. 1976;72:248–254.
32. Strowig T, Henao-Mejia J, Elinav E, Flavell R. Inflammasomes
in health and disease. Nature. 2012;481:278–286.
33. Feldmeyer L, Keller M, Niklaus G, Hohl D, Werner S, Beer
H. The inflammasome mediates UVB-induced activation and
secretion of interleukin-1beta by keratinocytes. Curr Biol.
2007;17:1140–1145.
34. Hasegawa T, Nakashima M, Suzuki Y. Nuclear DNA damage-
triggered NLRP3 inflammasome activation promotes UVB-
induced inflammatory responses in human keratinocytes.
Biochem Biophys Res Commun. 2016;477:329–335.
35. Bauernfeind F, Niepmann S, Knolle PA, Hornung V. Aging-
associated TNF production primes inflammasome activa-
tion and NLRP3-related metabolic disturbances. J Immunol.
2016;197:2900–2908.
36. Patel MN, Carroll RG, Galván-Peña S, et al. Inflammasome
priming in sterile inflammatory disease. Trends Mol Med.
2017;23:165–180.
37. Boersma PM, Haarsma LD, Schotanus MP, Ubels JL. TNF-
R1 and FADD mediate UVB-induced activation of K+ chan-
nels in corneal epithelial cells. Experimental Eye Research.
2017;154:1–9.
38. Bae JY, Park HH. Crystal structure of NALP3 protein pyrin
domain (PYD) and its implications in inflammasome assem-
bly. J Biol Chem. 2011;286:39528–39536.
39. Benko S, Tozser J, Miklossy G, et al. Constitutive and UV-
B modulated transcription of Nod-like receptors and their
functional partners in human corneal epithelial cells. Mol
Vis. 2008;14:1575–1583.
Downloaded from iovs.arvojournals.org on 06/16/2020
UCA Prevents UV-B-Induced Inflammasome Activation IOVS | April 2020 | Vol. 61 | No. 4 | Article 7 | 11
40. Piippo N, Korhonen E, Hytti M, et al. Hsp90 inhibition as a
means to inhibit activation of the NLRP3 inflammasome. Sci
Rep. 2018;8:6720.
41. Baroja-Mazo A, Martín-Sánchez F, Gomez AI, et al. The
NLRP3 inflammasome is released as a particulate danger
signal that amplifies the inflammatory response. Nat
Immunol. 2014;15:738–748.
42. Franklin BS, Bossaller L, De Nardo D, et al. The
adaptor ASC has extracellular and ’prionoid’ activities
that propagate inflammation. Nat Immunol. 2014;15:727–
737.
43. Niu L, Zhang S, Wu J, Chen L, Wang Y. Upregulation of
NLRP3 inflammasome in the tears and ocular surface of dry
eye patients. PLoS ONE. 2015;10:e0126277.
44. Álvarez S, Muñoz-Fernández MÁ. TNF-Α may mediate
inflammasome activation in the absence of bacterial infec-
tion in more than one way. PLoS ONE. 2013;8:e71477.
45. Banerjee Sanjita, Bond Judith S. Prointerleukin-18 is acti-
vated by meprin beta in vitro and in vivo in intesti-
nal inflammation. The Journal of Biological Chemistry.
2008;283:31371–31377.
46. Omoto Y, Yamanaka K, Tokime K, et al. Granzyme B is
a novel interleukin-18 converting enzyme. J Dermatol Sci.
2010;59:129–135.
47. Bossaller L, Chiang P, Schmidt-Lauber C, et al. Cutting
edge: FAS (CD95) mediates noncanonical IL-1β and IL-18
maturation via caspase-8 in an RIP3-independent manner. J
Immunol. 2012;189:5508–5512.
48. Omoto Y, Tokime K, Yamanaka K, et al. Human
mast cell chymase cleaves pro-IL-18 and generates a
novel and biologically active IL-18 fragment. J Immunol.
2006;177:8315–8319.
49. Hernandez-Pigeon H, Jean C, Charruyer A, et al. Human
keratinocytes acquire cellular cytotoxicity under UV-B irra-
diation. Implication of granzyme B and perforin. J Biol
Chem. 2006;281:13525–13532.
50. Jauhonen H, Kari E, Pylkkänen L, et al. A randomized phase
I clinical study of cis-urocanic acid eye drops in healthy
adult subjects. Acta Ophthalmol. 2015;93:368–376.
51. Peltonen JM, Pylkkänen L, Jansén CT, et al. Three
randomised phase I/IIa trials of 5% cis-urocanic acid
emulsion cream in healthy adult subjects and in patients
with atopic dermatitis. Acta Derm Venereol. 2014;94:415–
420.
52. Walterscheid JP, Nghiem DX, Kazimi N, et al. Cis-urocanic
acid, a sunlight-induced immunosuppressive factor, acti-
vates immune suppression via the 5-HT2A receptor. Proc
Natl Acad Sci USA. 2006;103:17420–17425.
53. Cloëz-Tayarani I, Petit-Bertron A, Venters HD, Cavaillon
J. Differential effect of serotonin on cytokine production
in lipopolysaccharide-stimulated human peripheral blood
mononuclear cells: involvement of 5-hydroxytryptamine2A
receptors. Int Immunol. 2003;15:233–240.
54. Dürk T, Panther E, Müller T, et al. 5-Hydroxytryptamine
modulates cytokine and chemokine production in LPS-
primed human monocytes via stimulation of different 5-HTR
subtypes. Int Immunol. 2005;17:599–606.
55. Laihia JK, Kallio JP, Taimen P, Kujari H, Kähäri V, Leino L.
Protodynamic intracellular acidification by cis-urocanic acid
promotes apoptosis of melanoma cells in vitro and in vivo.
J Invest Dermatol. 2010;130:2431–2439.
56. Rajamäki K, Nordström T, Nurmi K, et al. Extracellular
acidosis is a novel danger signal alerting innate immunity
via the NLRP3 inflammasome. J Biol Chem. 2013;288:13410–
13419.
57. Ubels JL, Van Dyken RE, Louters JR, Schotanus MP,
Haarsma LD. Potassium ion fluxes in corneal epithelial cells
exposed to UVB. Experimental Eye Research. 2011;92:425–
431.
58. Muñoz-Planillo R, Kuffa P, Martínez-Colón G, Smith B,
Rajendiran T, Núñez G. K+ efflux is the common trigger
of NLRP3 inflammasome activation by bacterial toxins and
particulate matter. Immunity. 2013;38:1142–1153.
59. Petrilli V, Papin S, Dostert C, Mayor A, Martinon F, Tschopp
J. Activation of the NALP3 inflammasome is triggered by
low intracellular potassium concentration. Cell Death and
Differentiation. 2007;14:1583–1589.
60. Zheng Q, Ren Y, Reinach PS, et al. Reactive oxygen species
activated NLRP3 inflammasomes initiate inflammation in
hyperosmolarity stressed human corneal epithelial cells
and environment-induced dry eye patients. Exp Eye Res.
2015;134:133–140.
Downloaded from iovs.arvojournals.org on 06/16/2020
